Product Details

Verodex is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Dexamethasone Sodium Phosphate equivalent to 4mg Dexamethasone per mL for use through the intramuscular (I.M.) or intravenous (I.V.) route. As a result, it offers a potent, fast-acting corticosteroid for the management of inflammatory and allergic conditions.

The injection contains:

• Dexamethasone Sodium Phosphate BP (equivalent to Dexamethasone 4mg per mL) – A synthetic corticosteroid with potent glucocorticoid activity. Consequently, it suppresses inflammation, modulates immune response, and reduces oedema across a wide range of clinical conditions.

Physicians use Verodex for the management of severe allergic reactions, anaphylaxis, cerebral oedema, inflammatory conditions, and as adjunctive therapy in certain shock states and respiratory conditions. In addition, its dual-route (I.M./I.V.) formulation allows flexible administration based on clinical urgency. Because of this profile, Verodex suits hospitals, emergency departments, and ICUs where rapid corticosteroid intervention is required.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the dual-route (I.M./I.V.) formulation offers flexible clinical use
• Furthermore, each vial delivers precise, validated dosage accuracy at 4mg/mL
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected vial packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, ICUs, and emergency care units